ES514918A0 - Un procedimiento para producir nuevos derivados de benzopirano y de cromano - Google Patents

Un procedimiento para producir nuevos derivados de benzopirano y de cromano

Info

Publication number
ES514918A0
ES514918A0 ES514918A ES514918A ES514918A0 ES 514918 A0 ES514918 A0 ES 514918A0 ES 514918 A ES514918 A ES 514918A ES 514918 A ES514918 A ES 514918A ES 514918 A0 ES514918 A0 ES 514918A0
Authority
ES
Spain
Prior art keywords
chem
general formula
hydrogen
compounds
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES514918A
Other languages
English (en)
Other versions
ES8403119A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Publication of ES8403119A1 publication Critical patent/ES8403119A1/es
Publication of ES514918A0 publication Critical patent/ES514918A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES514918A 1981-08-12 1982-08-11 Un procedimiento para producir nuevos derivados de benzopirano y de cromano Granted ES514918A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56126912A JPS5829782A (ja) 1981-08-12 1981-08-12 新規複素環化合物、その製法及び該化合物を含有する医薬組成物

Publications (2)

Publication Number Publication Date
ES8403119A1 ES8403119A1 (es) 1984-03-01
ES514918A0 true ES514918A0 (es) 1984-03-01

Family

ID=14946961

Family Applications (1)

Application Number Title Priority Date Filing Date
ES514918A Granted ES514918A0 (es) 1981-08-12 1982-08-11 Un procedimiento para producir nuevos derivados de benzopirano y de cromano

Country Status (10)

Country Link
US (1) US4545993A (es)
EP (1) EP0074170B1 (es)
JP (1) JPS5829782A (es)
KR (1) KR840001152A (es)
AT (1) ATE16106T1 (es)
AU (1) AU553826B2 (es)
CA (1) CA1211453A (es)
DE (1) DE3266943D1 (es)
DK (1) DK330182A (es)
ES (1) ES514918A0 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH651034A5 (de) * 1982-05-12 1985-08-30 Hoffmann La Roche Chroman-, thiochroman- oder 1,2,3,4-tetrahydrochinolinderivate und ihre verwendung als arzneimittel-wirkstoffe.
US4537903A (en) * 1983-10-12 1985-08-27 Merck & Co., Inc. Substituted cinnamyl-2,3-dihydrobenzofuran and analogs useful as anti-inflammatory agents
JPS61118380A (ja) * 1984-11-14 1986-06-05 Shionogi & Co Ltd 新規な1,4−ベンゾジオキサンおよび1,4−ベンゾジオキシン誘導体ならびにその製造法
JPH0723367B2 (ja) * 1986-02-27 1995-03-15 サントリー株式会社 オキサビシクロヘプタン誘導体
US5463059A (en) * 1992-11-10 1995-10-31 E. R. Squibb & Sons, Inc. Process for the preparation of intermediates useful in the preparation of pyranyl cyanoguanidine derivatives
JP2908957B2 (ja) * 1993-03-12 1999-06-23 財団法人生産開発科学研究所 新規なクロマン化合物及びその用途
PL330408A1 (en) * 1996-06-07 1999-05-10 Procter & Gamble Dihydrobenzopyrane and affinite compounds useful as antiinflammatory agents
KR20010100505A (ko) * 2000-05-03 2001-11-14 문형강 직물지의 다색날염방법 및 장치
WO2004087868A2 (en) * 2003-03-25 2004-10-14 Stratagene Dna polymerase fusions and uses thereof
US9573921B2 (en) * 2013-09-30 2017-02-21 Polfarmex S.A. Substituted N, N-dimethylaminoalkyl ethers of isoflavanone oximes as H1-receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842191B2 (ja) * 1975-11-07 1983-09-17 スタビリメンテイ シミシ フアルマス−テイシ リウニテイ シアパレリ ソチエタ ペル アツイオニ コウエンシヨウセイノジヒドロフランカン マタハ ジヒドロピランカンガンユウアリ−ルアルカンサンノ セイゾウホウ

Also Published As

Publication number Publication date
DE3266943D1 (en) 1985-11-21
DK330182A (da) 1983-02-13
US4545993A (en) 1985-10-08
JPH0234951B2 (es) 1990-08-07
ATE16106T1 (de) 1985-11-15
AU8655182A (en) 1983-02-17
CA1211453A (en) 1986-09-16
EP0074170A1 (en) 1983-03-16
JPS5829782A (ja) 1983-02-22
ES8403119A1 (es) 1984-03-01
EP0074170B1 (en) 1985-10-16
AU553826B2 (en) 1986-07-31
KR840001152A (ko) 1984-03-28

Similar Documents

Publication Publication Date Title
ES473074A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
ES514918A0 (es) Un procedimiento para producir nuevos derivados de benzopirano y de cromano
ES8504723A1 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.
ES2039221T3 (es) Procedimiento para producir derivados de piridazinona.
AU599227B2 (en) Bicyclic sulfonamide derivatives and process therefor
MX7122E (es) Procedimiento para la preparacion de derivados de tiometilpiridina
DK412581A (da) Ethenylimidazolderivater og fremgangsmaade til fremstilling heraf
ES425216A1 (es) Procedimiento para la preparacion de nuevas triazolo - 1,5 - benzodiazepinas sustituidas.
ES456400A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina.
ATE16593T1 (de) Polycyclische indol-derivate.
ES557204A0 (es) Procedimiento para la obtencion de piridazinonas sustituidas
GB2004885A (en) Indolopyrones
ES8308329A1 (es) "un metodo de preparar derivados de oxotienobenzoxepina".
KR840002360A (ko) 이미다졸 카르복시 유도체의 제조방법
KR860008965A (ko) 1,3-프로판디온 유도체를 제조하는 방법
SE7713779L (sv) Nya fenylderivat
JPS5473797A (en) Pyride 3.2.1-jk carbazole derivative
ES8403471A1 (es) Un procedimiento para preparar nuevos compuestos de cromanona.
SE8105297L (sv) Imidazolderivat
ES398368A1 (es) Un procedimiento para la preparacion de nuevos derivados de1,2,3,4 - tetrahidroisoquinoleina.
ES422608A1 (es) Procedimiento para la preparacion de nuevos compuestos de benzodiazepina.
ES8204736A1 (es) Un procedimiento para la preparacion de piridazopiridacina
ES483138A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina
ES401893A1 (es) Procedimiento para la preparacion de nuevos compuestos de benzodiacepina.
ATE17490T1 (de) Dithiino (1,4) (2,3-c) pyrrolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.